Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Oral bicalutamide is safe and effective for female hair loss.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Alternative treatments show promise for hair growth beyond traditional methods.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.